BCT fundamentals
An in-depth look to BRIACELL THERAPEUTICS CORP operating, investing, and financing activities
BCT free cash flow for Q4 24 is -6.25 M CAD. For 2024, BCT free cash flow was -33.41 M CAD and operating cash flow was -32.79 M CAD.
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CAD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM